<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.5-a.3'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//nxtin.health/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://nxtin.health/2026/11/17/biophot-drove-forward-66-innovation-projects-and-deepened-its-engagement-with-industry-during-its-first-phase/</loc>
  <lastmod>2026-11-17T12:43:12Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>“BioPhoT” drove forward 66 innovation projects and deepened its engagement with industry during its first phase</news:title>
   <news:publication_date>2026-11-17T12:43:10Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/17/slovenia-opens-e30m-funding-opportunity-for-biotech-and-pharma-companies/</loc>
  <lastmod>2026-11-17T10:39:12Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Slovenia opens €30M funding opportunity for biotech and pharma companies</news:title>
   <news:publication_date>2026-11-17T12:36:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/17/san-camillo-forlanini-a-community-hospital-opens-in-the-former-monaldi-pavilion/</loc>
  <lastmod>2026-11-17T12:23:25Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>San Camillo Forlanini: A Community Hospital Opens in the Former Monaldi Pavilion</news:title>
   <news:publication_date>2026-11-17T12:23:22Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/17/owen-smith-4bio-capital-approval-isnt-the-end-of-the-journey/</loc>
  <lastmod>2026-11-17T11:53:01Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Owen Smith, 4BIO Capital: Approval isn’t the end of the journey</news:title>
   <news:publication_date>2026-11-17T11:42:58Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/17/commit-biologics-announces-final-close-of-60m-seed-financing-to-advance-complement-powered-immune-engagers-toward-the-clinic/</loc>
  <lastmod>2026-11-17T11:12:56Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Commit Biologics announces final close of $60M seed financing to advance complement-powered immune engagers toward the clinic</news:title>
   <news:publication_date>2026-11-17T11:12:54Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/17/contour-medical-wins-medtech-world-startup-pitch-2026/</loc>
  <lastmod>2026-11-17T11:04:20Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Contour Medical wins MedTech World Startup Pitch 2026</news:title>
   <news:publication_date>2026-11-17T11:04:18Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/17/lucio-rovati-and-rottapharm-biotech-invest-in-neomatrix-an-italian-alliance-to-advance-the-development-of-personalized-cancer-vaccines/</loc>
  <lastmod>2026-11-17T10:51:47Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Lucio Rovati and Rottapharm Biotech invest in Neomatrix: an Italian alliance to advance the development of personalized cancer vaccines</news:title>
   <news:publication_date>2026-11-17T10:51:44Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/17/kaunas-clinics-use-the-da-vinci-robotic-surgical-system-to-treat-gastric-cancer/</loc>
  <lastmod>2026-11-17T09:15:50Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Kaunas clinics use the da Vinci Robotic surgical system to treat gastric cancer</news:title>
   <news:publication_date>2026-11-17T09:15:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/17/from-an-innovative-idea-to-a-successful-company-the-story-of-mesi-supported-by-the-slovene-enterprise-fund/</loc>
  <lastmod>2026-11-17T08:42:30Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>From an innovative idea to a successful company: the story of MESI, supported by the Slovene Enterprise Fund</news:title>
   <news:publication_date>2026-11-17T08:42:08Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/17/akara-raises-5-5m-to-bring-privacy-preserving-ai-to-hospitals/</loc>
  <lastmod>2026-11-17T07:30:40Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Akara raises $5.5M to bring privacy-preserving AI to hospitals</news:title>
   <news:publication_date>2026-11-17T07:30:38Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/inside-pentasweets-e65m-bet-on-brazzein-europes-first-sweet-protein-factory/</loc>
  <lastmod>2026-11-16T20:16:57Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Inside Pentasweet’s €65M bet on brazzein: Europe’s first sweet protein factory</news:title>
   <news:publication_date>2026-11-16T20:14:31Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/six-strengths-that-set-lithuania-apart-for-international-investors/</loc>
  <lastmod>2026-11-17T07:44:52Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Six strengths that set Lithuania apart for international investors</news:title>
   <news:publication_date>2026-11-16T15:39:56Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/ai-powered-protein-design-how-biomatter-is-transforming-global-biotech-and-sustainability/</loc>
  <lastmod>2026-11-16T15:39:36Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>AI-powered protein design: how Biomatter is transforming global biotech and sustainability</news:title>
   <news:publication_date>2026-11-16T15:39:36Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/why-cell-and-gene-therapy-manufacturing-is-expanding-in-europe/</loc>
  <lastmod>2026-11-17T08:08:58Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Why cell and gene therapy manufacturing is expanding in Europe</news:title>
   <news:publication_date>2026-11-16T15:39:09Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/5-biotech-companies-in-lithuania-to-watch-in-2026/</loc>
  <lastmod>2026-11-17T08:11:09Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>5 biotech companies in Lithuania to watch in 2026</news:title>
   <news:publication_date>2026-11-16T15:38:37Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/why-investors-choose-lithuania/</loc>
  <lastmod>2026-11-16T20:24:53Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Inside Pentasweet’s €65M bet on brazzein: Europe’s first sweet protein factory</news:title>
   <news:publication_date>2026-11-16T15:38:01Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/lithuanias-health-innovation-from-gene-editing-to-robotic-stroke-care-2/</loc>
  <lastmod>2026-11-17T08:05:27Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Lithuania’s health innovation: from gene editing to robotic stroke care</news:title>
   <news:publication_date>2026-11-16T15:37:30Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/healthcare-without-an-expiry-date-jean-claude-muscat-on-future-proof-hospitals/</loc>
  <lastmod>2026-11-16T12:30:42Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Healthcare without an expiry date: Jean-Claude Muscat on future-proof hospitals</news:title>
   <news:publication_date>2026-11-16T12:30:40Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/fresenius-and-wuxi-biologics-enter-exclusive-development-agreement-to-expand-biosimilars-pipeline/</loc>
  <lastmod>2026-11-16T12:02:59Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Fresenius and WuXi Biologics enter exclusive development agreement to expand biosimilars pipeline</news:title>
   <news:publication_date>2026-11-16T12:02:57Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/sofinnova-partners-closes-e725m-crossover-ii-fund/</loc>
  <lastmod>2026-11-16T11:41:38Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Sofinnova Partners closes €725M Crossover II Fund</news:title>
   <news:publication_date>2026-11-16T11:41:36Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/teleclinic-expands-into-switzerland-through-acquisition-of-medi24/</loc>
  <lastmod>2026-11-16T12:51:45Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>TeleClinic expands into Switzerland through acquisition of Medi24</news:title>
   <news:publication_date>2026-11-16T10:47:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/eu-and-singapore-team-up-on-medicines-and-medical-device-safety/</loc>
  <lastmod>2026-11-16T12:44:56Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>EU and Singapore team up on medicines and medical device safety</news:title>
   <news:publication_date>2026-11-16T08:44:24Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/htl-biotechnology-launches-htl8-a-production-unit-dedicated-to-pharmaceutical-grade-polynucleotides/</loc>
  <lastmod>2026-11-16T10:18:49Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>HTL Biotechnology launches HTL8, a production unit dedicated to pharmaceutical-grade polynucleotides</news:title>
   <news:publication_date>2026-11-16T08:39:09Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/building-cardiolyse-the-distance-from-a-good-algorithm-to-a-doctors-desk/</loc>
  <lastmod>2026-11-16T20:02:39Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Building Cardiolyse - the distance from a good algorithm to a doctor&amp;#039;s desk</news:title>
   <news:publication_date>2026-11-16T08:23:58Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/european-commission-publishes-joint-clinical-assessment-report-on-new-breast-cancer-medicine/</loc>
  <lastmod>2026-11-16T08:02:02Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>European Commission publishes joint clinical assessment report on new breast cancer medicine</news:title>
   <news:publication_date>2026-11-16T08:02:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/strengthening-hospital-resilience-santaros-klinikos-teams-up-with-vilnius-tech/</loc>
  <lastmod>2026-11-17T10:05:55Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Strengthening hospital resilience: Santaros Klinikos teams up with VILNIUS TECH</news:title>
   <news:publication_date>2026-11-16T00:01:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/15/the-eu-wants-to-reach-zero-road-deaths-by-2050/</loc>
  <lastmod>2026-11-15T15:06:01Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>The EU wants to reach zero road deaths by 2050</news:title>
   <news:publication_date>2026-11-15T15:05:58Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>